InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the full record of transactions filed by Fairman Jeff, Vice-Président de la Recherche. Insider active across 1 companies, notably Vaxcyte, Inc.. Cumulatively, 25 filings have been logged. Total volume traded: €470k. The latest transaction was filed on 20 May 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations25 total
€99,1174,112 shares@ €24.10440.0016% mcap16.9% of flow
Common Stock
SEC:0001209191-22-031619:0·
€21,741888 shares@ €24.48310.0004% mcap3.7% of flow
Common Stock
SEC:0001209191-22-027848:0·
€117,3165,000 shares@ €23.46320.0019% mcap20.0% of flow
Common Stock
SEC:0001209191-22-023695:0·
€231,52510,000 shares@ €23.15250.0038% mcap39.5% of flow
Common Stock
SEC:0001209191-22-019027:0·
06,000 shares0
Common Stock
SEC:0001209191-22-016524:0·
€7,1154,469 shares@ €1.5920.0001% mcap12.2% of flow
Common Stock
SEC:0001209191-22-007789·
€7,1154,469 shares@ €1.5920.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-22-007789:0·
€7,5084,750 shares@ €1.58070.0001% mcap12.8% of flow
Common Stock
SEC:0001209191-21-071376·
€7,5084,750 shares@ €1.58070.0001% mcap1.3% of flow
Common Stock
SEC:0001209191-21-071376:0·
€7,3234,619 shares@ €1.58540.0001% mcap12.5% of flow
Common Stock
SEC:0001209191-21-070572·
€7,3234,619 shares@ €1.58540.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-21-070572:0·
€207131 shares@ €1.57770.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-069292·
€207131 shares@ €1.57770.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-069292:0·
€7,3314,750 shares@ €1.54330.0001% mcap12.5% of flow
Common Stock
SEC:0001209191-21-061940·
€7,3314,750 shares@ €1.54330.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-21-061940:0·
€7,2694,750 shares@ €1.53030.0001% mcap12.4% of flow
Common Stock
SEC:0001209191-21-058125·
€7,2694,750 shares@ €1.53030.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-21-058125:0·
€7,2324,750 shares@ €1.52260.0001% mcap12.4% of flow
Common Stock
SEC:0001209191-21-053901·
€7,2324,750 shares@ €1.52260.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-21-053901:0·
€7,2014,750 shares@ €1.5160.0001% mcap12.3% of flow
Common Stock
SEC:0001209191-21-048429·
€7,2014,750 shares@ €1.5160.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-21-048429:0·
€7,1284,750 shares@ €1.50060.0001% mcap12.2% of flow
Common Stock
SEC:0001209191-21-044018·
€7,1284,750 shares@ €1.50060.0001% mcap1.2% of flow
Common Stock
SEC:0001209191-21-044018:0·
€2387,259 shares@ €0.03280.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-039204:0·
€2387,259 shares@ €0.03280.0000% mcap0.4% of flow
Common Stock
SEC:0001209191-21-039204·
25 of 25 declarations
About Fairman Jeff
Jeff Fairman is an executive at Vaxcyte, Inc.
